Literature DB >> 23173267

[The application of qi benefiting and blood activating method in thrombolytic therapy of acute cerebral infarction].

Rui-huan Pan1, Yan Huang.   

Abstract

The thrombolytic therapy has been widely used in treating acute cerebral infarction (ACI), but various severe complications restrict its clinical application. However, Chinese medicine shows its advantages in the treatment of ACI after thrombolytic therapy. Qi benefiting and blood activating method is an important principle and mean for supporting the vital qi and removing the surplus evil. By using this method, its short-term and long-term efficacy could be improved after thrombolytic therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23173267

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  The combination of Astragalus membranaceus extract and ligustrazine to improve the inflammation in rats with thrombolytic cerebral ischemia.

Authors:  Ruihuan Pan; Mingchao Zhou; Yiping Zhong; Jingping Xie; Shanshan Ling; Xialin Tang; Yan Huang; Hongxia Chen
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

2.  The Effect of Naoxintong Capsule in the Treatment of Patients with Cerebral Infarction and Carotid Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Qiuer Liang; Yunfei Cai; Ruixue Chen; Weihao Chen; Liguo Chen; Ya Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-24       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.